title: Olanzapine usage associated with neuroleptic malignant syndrome.
authors.affiliation: Department of Psychiatry, University of Iowa, Iowa City 52246, USA. robert-philibert@uiowa.edu
authors.forename: R A
authors.initials: RA
authors.lastname: Philibert
authors.forename: L A
authors.initials: LA
authors.lastname: Adam
authors.forename: F M
authors.initials: FM
authors.lastname: Frank
authors.forename: C
authors.initials: C
authors.lastname: Carney-Doebbeling
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D003863:Depression / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D010300:Parkinson Disease / Q000150:complications*; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012074:Remission Induction; D013406:Suicide, Attempted
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine